跳至主要内容
临床试验/NCT05087251
NCT05087251进行中(未招募)不适用

Randomized Trial of an Intervention to Enhance Quality of Life in Adults Completing Lung Cancer Treatment With Curative Intent

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
2
主要终点
Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer

研究概览

简要总结

The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.

详细描述

This is a randomized controlled trial to test the efficacy of a brief psychoeducational intervention relative to a control condition for improving quality of life in patients with lung cancer who are transitioning from treatment to surveillance.

In this study, participants will complete survey questions and will be randomly assigned to receive a 5-session program or a 1-session program.

It is expected that about 100 people will take part in this research study.

The American Lung Association is supporting this research by providing funding for the research study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 or older
  • Able to read and respond in English
  • Diagnosis of non-small cell lung cancer or small cell lung cancer
  • Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery
  • Completed cancer treatment within past 3 weeks
  • If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete
  • If final treatment is surgery: within 3 weeks after hospital discharge following surgery

排除标准

  • Comorbid health condition that would interfere with study participation
  • Current participation in cognitive behavioral therapy treatment

结局指标

主要结局

Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer

时间窗: Up to 12 weeks

We will investigate longitudinal differences in quality of life between study groups (Functional Assessment of Cancer Therapy-Lung Cancer score range 0-144, with higher scores indicating better quality of life)

次要结局

  • Fear of cancer recurrence: Fear of Cancer Recurrence Scale 7(Up to 12 weeks)
  • Symptom burden: Edmonton Symptom Assessment Scale(Up to 12 weeks)
  • Psychological symptom burden: Hospital Anxiety and Depression Scale(Up to 12 weeks)
  • Social support: Multidimensional Scale of Perceived Social Support(Up to 12 weeks)
  • Social isolaton: Campaign to End Loneliness Measurement Tool(Up to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lara Traeger

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

The Transitions Project: Efficacy Trial | 临床试验